Research Article

Impact of Lipoprotein(a) on Macrovascular Complications of Diabetes in a Multiethnic Population in the French Amazon

Table 4

Distribution of the number (No.) of patients by diabetes-related macrovascular complications according to lipoprotein(a) level.

Lp(a) 0-75 mg/mLLp(a) 76-300 mg/mLLp(a) >300 mg/mL valueTotal

Macrovascular complicationsNo. (%)
Angina
 Yes6 (4.96)4 (2.80)12 (4.94)0.3022 (4.34)
 No110 (90.91)138 (96.50)226 (93.00)474 (93.49)
 Unknown5 (4.13)1 (0.70)5 (2.06)11 (2.17)
Transient ischemic attack
 Yes10 (8.20)1 (0.70)10 (4.13)0.05021 (4.15)
 No110 (90.16)138 (97.18)226 (93.39)474 (93.68)
 Unknown2 (1.64)3 (2.11)6 (2.48)11 (2.17)
Stroke
 Yes15 (12.30)8 (5.63)21 (8.64)0.3044 (8.68)
 No106 (86.89)134 (94.37)221 (90.95)461 (90.93)
 Unknown1 (0.82)0 (0.00)1 (0.41)2 (0.39)
Arteriopathy
 Yes12 (6.06)8 (3.64)28 (7.25)0.3848 (5.97)
 No160 (80.81)177 (80.45)309 (80.05)646 (80.35)
 Unknown26 (13.13)35 (15.91)49 (12.69)110 (13.68)